A review of how far GLP-1 agonists have come – drugs for type 2 diabetes that help with not only blood sugar management, but with weight loss and heart health too GLP-1 agonists entered the type 2 ...

aThe First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, 471003, China bLuoyang Key Laboratory of Clinical Multiomics and Translational ...

The last-minute save of PEPFAR is welcome but doesn't undo the damage that occurred, one noted ...

GLP-1s seem to be fertile ground for a variety of health benefits. Now, new findings suggest GLP-1s — popularly sold under brand names like Ozempic and Mounjaro —could improve a number of male ...

In this real-world study of patients with type 2 diabetes, treatment with semaglutide resulted in greater reductions in body weight and hemoglobin A1c than dulaglutide. Objective: To compare the ...

A growing body of evidence suggests that popular GLP-1 drugs, widely used for weight loss and diabetes, can provide protection against many types of cancer. More than two dozen studies presented over ...

A wave of expiries will hit high-value assets, including Keytruda, Eliquis, Ibrance, and Trulicity, amplifying revenue vulnerability for companies with concentrated blockbuster dependence.

Carley is a writer, editor and social media professional. Before starting at Forbes Health, she wrote for Sleepopolis and interned at PBS and Nickelodeon. She's a certified sleep science coach and ...

Isabel Casimiro, MD, PhD, is board-certified in internal medicine and works as an endocrinologist at the University of Chicago. Blood sugar levels for older adults should be monitored regularly ...

Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...

Alex Yampolsky, PharmD, is a clinical pharmacist at Elizabeth Seton Children’s Center, a pediatric long-term care facility in Yonkers, New York. If your current medications aren't controlling your ...

The findings, which come amid FDA scrutiny of Foundayo’s safety, will enable Lilly to seek a new clearance in diabetes. Drugs that act on the metabolic hormone GLP-1 were first sold for diabetes. The ...